Publications:

---

The evolving proteome of SARS-CoV-2 predominantly uses mutation combination strategy for survival.

Computational And Structural Biotechnology Journal

Patro, L Ponoop Prasad LPP; Sathyaseelan, Chakkarai C; Uttamrao, Patil Pranita PP; Rathinavelan, Thenmalarchelvi T

Publication Date: 2021

Variant appearance in text: SI: D839Y

PubMed Link: 34109017

Variant Present in the following documents:

• mmc10.xlsx, sheet 1

View BVdb publication page

---

Pediatric Inflammatory Multisystem Syndrome and Rheumatic Diseases During SARS-CoV-2 Pandemic.

Frontiers In Pediatrics

Schvartz, Adrien A; Belot, Alexandre A; Kone-Paut, Isabelle I

Publication Date: 2020

Variant appearance in text: SI: D839Y

PubMed Link: 33344389

Variant Present in the following documents:

• fped-08-605807.pdf

View BVdb publication page

---

Variations in SARS-CoV-2 Spike Protein Cell Epitopes and Glycosylation Profiles During Global Transmission Course of COVID-19.

Frontiers In Immunology

Xu, Wenxin W; Wang, Mingjie M; Yu, Demin D; Zhang, Xinxin X

Publication Date: 2020

Variant appearance in text: SI: D839Y

PubMed Link: 33013929

Variant Present in the following documents:

• fimmu-11-565278.pdf

View BVdb publication page

---

Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation.

Proceedings Of The National Academy Of Sciences Of The United States Of America

Cheng, Mary Hongying MH; Zhang, She S; Porritt, Rebecca A RA; Noval Rivas, Magali M; Paschold, Lisa L; Willscher, Edith E; Binder, Mascha M; Arditi, Moshe M; Bahar, Ivet I

Publication Date: 2020-10-13

Variant appearance in text: SI: D839Y

PubMed Link: 32989130

Variant Present in the following documents:

• Main text

View BVdb publication page

---

An insertion unique to SARS-CoV-2 exhibits superantigenic character strengthened by recent mutations.

Biorxiv : The Preprint Server For Biology

Cheng, Mary Hongying MH; Zhang, She S; Porritt, Rebecca A RA; Arditi, Moshe M; Bahar, Ivet I

Publication Date: 2020-05-21

Variant appearance in text: SI: D839Y

PubMed Link: 32511374

Variant Present in the following documents:

• Main text
• nihpp-2020.05.21.109272.pdf

View BVdb publication page

---

Latency and interval therapy affect the evolution in metastatic colorectal cancer.

Scientific Reports

Nikbakht, Hamid H; Jessa, Selin S; Sukhai, Mahadeo A MA; Arseneault, Madeleine M; Zhang, Tong T; Letourneau, Louis L; Thomas, Mariam M; Bourgey, Mathieu M; Roehrl, Michael H A MHA; Eveleigh, Robert R; Chen, Eric X EX; Krzyzanowska, Monika M; Moore, Malcolm J MJ; Giesler, Amanda A; Yu, Celeste C; Bedard, Philippe L PL; Kamel-Reid, Suzanne S; Majewski, Jacek J; Siu, Lillian L LL; Riazalhosseini, Yasser Y; Graham, Donna M DM

Publication Date: 2020-01-17

Variant appearance in text: SI: D839Y

PubMed Link: 31953485

Variant Present in the following documents:

• 41598_2020_57476_MOESM5_ESM.xlsx, sheet 1
• 41598_2020_57476_MOESM5_ESM.xlsx, sheet 11

View BVdb publication page

---

Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets.

Nature Communications

Witkiewicz, Agnieszka K AK; McMillan, Elizabeth A EA; Balaji, Uthra U; Baek, GuemHee G; Lin, Wan-Chi WC; Mansour, John J; Mollaee, Mehri M; Wagner, Kay-Uwe KU; Koduru, Prasad P; Yopp, Adam A; Choti, Michael A MA; Yeo, Charles J CJ; McCue, Peter P; White, Michael A MA; Knudsen, Erik S ES

Publication Date: 2015-04-09

Variant appearance in text: SI: D839Y

PubMed Link: 25855536

Variant Present in the following documents:

• ncomms7744-s2.xlsx, sheet 1

View BVdb publication page

---